We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Spice Suppresses Tumor Growth

By Biotechdaily staff writers
Posted on 21 Jul 2005
Curcumin, the yellow component in the spice turmeric and a major ingredient in yellow curry, has been found to suppress melanoma cell growth and trigger tumor cell death, according to new research.

This study also clarifies curcumin's intracellular processes of action in this kind of tumor. More...
The spice also demonstrates anti-inflammatory and antioxidant effects, as well as its anticancer characteristics. In other types of tumors, it has been shown to suppress tumor growth and trigger apoptosis, an intracellular process for cells to commit suicide. To assess the efficacy of curcumin in melanoma, researchers from the University of Texas M.D. Anderson Cancer Center (Houston, TX, USA) treated with melanoma cell lines with curcumin at different doses and for different duration.

The study's findings demonstrated that curcumin treatment decreased cell viability in all three cell lines in a dose-dependent manner. Furthermore, curcumin triggered apoptosis in tumor cells at high concentrations for short periods of time and decreased concentrations for long periods of time--a new finding in the evaluation of curcumin.

Curcumin was found to inhibit two specific proteins normally part of an intracellular pathway that prevents apoptosis when stimulated. Curcumin partially inhibited nuclear factor (NF)-kappa-B and strongly inhibited its upstream stimulator and another independent inhibitor of apoptosis, IKK. However, it did not suppress two other signaling pathways associated with melanomas and tumor proliferation, B-Raf/MEK/ERK and Akt pathways.

"Based on our studies, we conclude the curcumin is a potent suppressor of cell viability and inducer of apoptosis in melanoma cell lines,” reported the authors, adding "Future investigation to determine the effects of curcumin in animal models of melanoma and clinical trials are planned.”

The researchers published their study in the August 15, 2005, issue of the journal Cancer.



Related Links:
M.D. Anderson Cancer Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.